Clinical Trial Update: Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing dose-related efficacy of LAS41004 for psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• LAS41004

Snippet

Sponsor: Almirall, S.A. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED